跳至主要内容
临床试验/NCT01894204
NCT01894204终止不适用

Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study " PADIS HTP "

University Hospital, Brest16 个研究点 分布在 1 个国家目标入组 235 人开始时间: 2013年6月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
235
试验地点
16
主要终点
Frequency of a HTPPE

研究概览

简要总结

Forward-looking troop established(constituted) by the patients having been included in the study " PADIS EP ", PHRC on 2006 and 2009, randomized checked(controlled), double-blind, comparing an anticoagulating treatment(processing) extended by coumadine versus placebo during 18 months at patients having had a first episode of EP idiopathique treated(handled) initially 6 months by anti-vitamin K.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients having ended the study PADIS EP after the visit of the end of study and having signed the consent HTP.

排除标准

  • Refusal to grant in writing to participate in the study PADIS HTP

研究组 & 干预措施

HTPPE

Other

No drug and no placebo were used in this study. For all the patients who participated at the study PADIS-EP, somme exams must be performed.

干预措施: HTPPE (Other)

结局指标

主要结局

Frequency of a HTPPE

时间窗: 24 months

次要结局

  • Mortality and cause(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验